Rephonic
Artwork for ASCO Guidelines
ASCO Guidelines
Breast Cancer
Non-Small Cell Lung Cancer
Cancer Treatment
Chemotherapy
ASCO Living Guideline
Radiation Therapy
Immunotherapy
Cancer-Related Fatigue
American Society Of Clinical Oncology
Systemic Therapy
Multiple Myeloma
Metastatic Castration-Resistant Prostate Cancer
Hepatocellular Carcinoma
Stage I-Iii Anal Squamous Cell Carcinoma
ASCO Living Guidelines
Oncology
Hematopoetic Colony Stimulating Factors
Germline Testing
EGFR Mutations

ASCO Guidelines Podcast breaks down pivotal recommendations from the latest evidence-based clinical practice guidance and provides insight into daily patient care. Listen to stay up to date with the ever-evolving landscape of cancer research and treatment.

PublishesTwice monthlyEpisodes199Founded8 years ago
Number of ListenersCategories
Health & FitnessMedicine

Listen to this Podcast

Artwork for ASCO Guidelines

Latest Episodes

Dr. Rahul Banerjee joins the podcast to discuss the latest update to the living guideline on the treatment of multiple myeloma. He explains how sensational results from the MajesTEC-3 trial, which evaluated teclistamab plus daratumumab, prompted a ma... more

YouTube

Drs. Tina Lockwood and Stacy Gray share the newly released evidence-based guideline on circulating tumor DNA (ctDNA) testing from ASCO. They highlight recommendations on when ctDNA testing should be offered—including scenarios where tissue biopsies a... more

YouTube

Dr. Joshua Reuss returns to the podcast to discuss the update to the living guideline on stage IV NSCLC with driver alterations. The conversation focuses on new cancer treatment strategies for patients with advanced NSCLC and EGFR mutations, includin... more

YouTube

Dr. Lyudmila Bazhenova joins the podcast to share the update to the living guideline on stage IV NSCLC without driver alterations. Dr. Bazhenova discusses the evidence reviewed for both non-squamous NSCLC, including the POD1IM-304 and BAP BRAIN trial... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

ASCO Daily News
ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)
Two Onc Docs
Two Onc DocsSam and Karine
ASCO Education
ASCO EducationAmerican Society of Clinical Oncology (ASCO)
Journal of Clinical Oncology (JCO) Podcast
Journal of Clinical Oncology (JCO) PodcastAmerican Society of Clinical Oncology (ASCO)
NEJM This Week
NEJM This WeekNEJM Group

Recent Guests

Rahul Banerjee
Lead author on Treatment of Multiple Myeloma, ASCO Living Guideline
Fred Hutchinson Cancer Center
Episode: Treatment of Multiple Myeloma: ASCO Living Guideline Update 2026.1.1
Tina Lockwood
Co-chair, University of Washington School of Medicine
University of Washington School of Medicine
Episode: Circulating Tumor DNA Testing in Solid Tumors and Lymphoma Guideline
Stacy Gray
Co-chair, City of Hope
City of Hope
Episode: Circulating Tumor DNA Testing in Solid Tumors and Lymphoma Guideline
Joshua Reuss
Lead author on Therapy for Stage IV Non-Small Cell Lung Cancer with Driver Alterations, ASCO Living Guideline
Georgetown University
Episode: Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 2
Lyudmila Bazhenova
Lead author on Therapy for Stage IV Non-Small Cell Lung Cancer without Driver Alterations, ASCO Living Guideline
University of California San Diego Moores Cancer Center
Episode: Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 1
Nabil Saba
Lead author on Systemic Treatment of Thyroid Cancer, ASCO Guideline
Emory University
Episode: Systemic Treatment of Thyroid Cancer Guideline
Timothy Gilligan
From Taussig Cancer Institute and Center for Excellence in Healthcare Communication, Cleveland Clinic
Cleveland Clinic
Episode: Patient-Clinician Communication Guideline Update
Calvin Chou
From University of California and VA Health Care System, San Francisco
University of California, Veterans Affairs Health Care System
Episode: Patient-Clinician Communication Guideline Update
Dr. Bishal Gyawali
Co-chair of White Blood Cell Growth Factors ASCO Guideline Update
Queen's University
Episode: White Blood Cell Growth Factors Guideline Update

Host

Brittany Harvey
Host of ASCO Guidelines Podcast

Reviews

4.6 out of 5 stars from 74 ratings
  • ASCO Guidelines podcast

    Excellent podcasts

    Apple Podcasts
    5
    MakeABetterWay
    United Statesa year ago
  • Management of Anxiety and Depression for Survivors

    Excellent summary!

    Apple Podcasts
    5
    MakeABetterWay
    United States3 years ago
  • Helpful and engaging!

    Great way to keep tabs on the latest innovations in oncology, all while raising up a range of voices in the practice. And an excellent host!

    Apple Podcasts
    5
    esg311
    United States6 years ago
  • Excellent and informative

    This podcast is always educational, organized, and succinct. An excellent program!

    Apple Podcasts
    5
    &rew125
    United States6 years ago
  • Helpful - and short- podcasts

    I think this podcast is great becuase it's usually very relevant to practicing oncologists but it's also quick. I can generally listen to it over my commute.

    Apple Podcasts
    5
    NellyLoCo
    United States6 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Some episodes note audio quality issues that can be distracting.
Excellent host guiding rigorous clinical discussions.
Very informative and well organized; succinct for busy clinicians.
Clear, concise updates on evolving oncology guidelines.
Great way to stay current on oncology practices and guideline implications.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Treatment of Multiple Myeloma: ASCO Living Guideline Update 2026.1.1
Q: What should clinicians know as they implement this updated recommendation for their patients with multiple myeloma?
Clinicians should emphasize individualized shared decision-making between CAR-T and bispecifics, recognize that these immunotherapies are now on equal footing in relapse, and involve patients in discussions about access, logistics, and potential side effects while considering referral to centers offering CAR-T to ensure balanced options.
Treatment of Multiple Myeloma: ASCO Living Guideline Update 2026.1.1
Q: What evidence prompted this latest update and how did that impact the guideline recommendations?
The Majestic 3 trial and the rapid emergence of bispecific antibodies and CAR-T therapies in early relapse drove a shift toward prioritizing immune-based regimens (like Teclistoma plus Deratumumab) over traditional triplets, with a move to consider CAR-T or bispecifics as first-line options in relapse settings when feasible.
Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 1
Q: Great. Thank you for that context. Then based off this regular review of the evidence, what updated evidence did the panel identify on first-line treatment options for patients with non-squamous cell carcinoma, good performance status, and any PD-L1 expression, and how did this impact the recommendations of the guideline?
The panel identified three relevant manuscripts, including Podium 304 and the BEP brain data, plus Harmony 6 for squamous cell carcinoma, with Podium 304 supporting the addition of immunotherapy to chemotherapy in some scenarios, BEP brain providing context for Bevacizumab use in brain metastases, and Harmony 6 offering insights but not changing recommendations due to population limits and follow-up duration. The review also added Retifanlimab as an additional first-line option without displacing existing standard regimens.
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 2
Q: How do the new data affect frontline options for classical EGFR mutations like exon 19 deletion and L858R?
Two combination strategies have been approved in the frontline setting that may improve overall survival compared with osimertinib monotherapy, leading to a nuanced choice depending on patient-specific factors and access considerations.
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 2
Q: What prompted this latest update and changes to the recommendations?
The panel emphasized ongoing literature review to identify practice-changing data, ensuring the guideline remains up-to-date with the latest, most data-driven treatment decisions for patients globally.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About ASCO Guidelines

What is ASCO Guidelines about and what kind of topics does it cover?

A clinically focused show that distills evolving oncology guidelines and their practical impact on patient care. Episodes center on ASCO Living Guidelines across tumor types (myeloma, NSCLC, thyroid cancer, prostate cancer, breast cancer, and pregnancy-related cancer management), as well as related topics such as circulating tumor DNA, biomarkers, and guideline methodology. The host guides expert guideline authors and clinicians through evidence updates, implementation challenges, and real-world decision-making, often weighing trade-offs between emerging therapies (like immunotherapies and targeted agents) and traditional regimens. The format is concise and practitioner-oriented, with an emphasis on actionable takeaways, practical considera... more

Where can I find podcast stats for ASCO Guidelines?

Rephonic provides a wide range of podcast stats for ASCO Guidelines. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to ASCO Guidelines and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does ASCO Guidelines get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for ASCO Guidelines, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for ASCO Guidelines?

Rephonic provides comprehensive predictive audience data for ASCO Guidelines, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does ASCO Guidelines have?

To see how many followers or subscribers ASCO Guidelines has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to ASCO Guidelines?

These podcasts share a similar audience with ASCO Guidelines:

1. ASCO Daily News
2. Two Onc Docs
3. ASCO Education
4. Journal of Clinical Oncology (JCO) Podcast
5. NEJM This Week

How many episodes of ASCO Guidelines are there?

ASCO Guidelines launched 8 years ago and published 199 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact ASCO Guidelines?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for ASCO Guidelines?

Rephonic pulls ratings and reviews for ASCO Guidelines from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for ASCO Guidelines?

Rephonic provides full transcripts for episodes of ASCO Guidelines. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on ASCO Guidelines?

Recent guests on ASCO Guidelines include:

1. Rahul Banerjee
2. Tina Lockwood
3. Stacy Gray
4. Joshua Reuss
5. Lyudmila Bazhenova
6. Nabil Saba
7. Timothy Gilligan
8. Calvin Chou

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days